1.
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
by Stephens, N.G
The Lancet (British edition), 1996, Vol.347 (9004), p.781-786
2.
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
by Ericsson, C-G
The Lancet (British edition), 1996, Vol.347 (9005), p.849-853
3.
Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys
by CLARKSON, T. B
The journal of clinical endocrinology and metabolism, 1998, Vol.83 (3), p.721-726
4.
Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide
by Suzuki, Jun-Ichi
Nature medicine, 1997, Vol.3 (8), p.900-903
5.
Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes
by Sattar, Naveed
The Lancet (British edition), 1999, Vol.354 (9177), p.487-488
6.
Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Artery Disease
by Ashraf, Talat
The American journal of cardiology, 1996, Vol.78 (4), p.409-414
7.
Design & Rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
by Downs, John R
The American journal of cardiology, 1997, Vol.80 (3), p.287-293
8.
Statin trials and goals of cholesterol-lowering therapy after AMI
by Pedersen, Terje R
The American heart journal, 1999, Vol.138 (2), p.S177-S182
9.
Preventing and arresting coronary atherosclerosis
by Roberts, William Clifford
The American heart journal, 1995, Vol.130 (3), p.580-600
10.
Postmenopausal use of estrogen and occlusion of coronary arteries
by Gruchow, H.W
The American heart journal, 1988, Vol.115 (5), p.954-963
11.
Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)
by Byington, Robert P
The American journal of cardiology, 1997, Vol.80 (8), p.1087-1090
12.
Cholesterol lowering and coronary artery disease: mechanisms of risk reduction
by Archbold, R A
Heart, 1998, Vol.80 (6), p.543-547
13.
Prevention of restenosis after percutaneous transluminal coronary angioplasty: The search for a “magic bullet”
by Hermans, Walter R.M
The American heart journal, 1991, Vol.122 (1), p.171-187
14.
Future cardiovascular end point studies : Where will the research take us?
by LAROSA, J. C
The American journal of cardiology, 1999, Vol.84 (4), p.454-458
15.
Long-term epidemiologic prediction of coronary disease. The Framingham experience
by Kannel, W B
Cardiology, 1993, Vol.82 (2-3), p.137-152
16.
Coronary heart disease: Overview
by Henderson, Andrew
The Lancet (British edition), 1996, Vol.348, p.S1-S4
17.
On the statins, correcting plasma lipid levels, and preventing the clinical sequelae of atherosclerotic coronary heart disease
by Krut, L H
The American journal of cardiology, 1998, Vol.81 (8), p.1045-1046
18.
Comment on Lack of Effect of Raloxifene on Coronary Artery Atherosclerosis of Postmenopausal Monkeys
by Bryant, Henry U
The journal of clinical endocrinology and metabolism, 1998, Vol.83 (8), p.3001-a-3002
19.
Atherosclerosis Regression, Plaque Disruption, and Cardiovascular Events: A Rationale for Lipid Lowering in Coronary Artery Disease
by Brown, B G
Annual review of medicine, 1993, Vol.44 (1), p.365-376
20.
The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: Clinical evidence from the physicians' health study
by Ridker, Paul M
The American heart journal, 1991, Vol.122 (6), p.1588-1592
Filter electronic articles 347 Hits
Remove Filters
